Teva Pharmaceutical Industries (TEVA) Revenue and Net Income History

Historical revenue, operating income and net income for Teva Pharmaceutical Industries (TEVA) over the last 10 years. The current TTM revenue for Teva Pharmaceutical Industries as of December 14, 2017 is $21.9B.

Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $17.577B $21.903B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.